Browsing Tag

Partnering

580 posts

Roche, Dicerna Form $1.67-Bn Deal for Hepatitis B Treatments
By

By
Roche has formed a research collaboration and licensing agreement with Dicerna Pharmaceuticals, a developer of RNAi medicines, in a deal worth up to $1.67 billion focused on developing treatments for…

Amgen, BeiGene in $2.7-Bn Oncology Pact for China
By

By
Amgen has entered into a global strategic oncology collaboration with BeiGene, a Beijing-headquartered company, under which Amgen will acquire an equity stake in BeiGene for approximately $2.7 billion. The companies…

Roivant, Sumitomo Dainippon Pharma Form $3-Bn Alliance
By

By
Roivant Sciences, a New York-based healthcare company, and Sumitomo Dainippon Pharma, have signed a definitive agreement for the creation of a broad strategic alliance and to form a new company…

Gilead, Glympse Bio in NASH Drug Pact
By

By
Gilead Sciences and Glympse Bio, a developer of non-invasive technology for disease activity, have entered into a strategic collaboration for nonalcoholic steatohepatitis (NASH) clinical development. Glympse Bio’s proprietary synthetic biomarkers,…

Takeda in $420 M-Deal for Celiac Disease Drug
By

By
Takeda Pharmaceutical has acquired an exclusive global license, worth up to $420 million, from Chicago-based COUR Pharmaceutical Development Company for developing and commercializing an investigational medicine for treating celiac disease.…

Novo Nordisk, Bluebird Bio Partner to Develop Gene Therapies
By

By
Novo Nordisk and Bluebird Bio, a developer of gene therapies for severe genetic diseases and cancer, have entered into a three-year research collaboration to jointly develop in vivo genome-editing treatments…

GSK, Lyell Immunopharma Form Pact for Cancer Cell Therapies
By

By
GlaxoSmithKline (GSK) has formed a five-year collaboration with Lyell Immunopharma, a San Francisco-based adoptive cell therapy biotechnology company, to develop new technologies for cell therapies for treating solid tumors. The…

Global Pharma Briefs: News from Asia and the US
By

By
A roundup of developments and latest news from China (Biocad, Shanghai Pharma), India (Aurobindo, Glenmark, Lupin), and the US (Astellas). China Russia’s Biocad, Shanghai Pharma Finalize Joint Venture Biocad, a…

Pfizer, Akcea in $1.3-Billion-Plus Pact for Investigative Antisense Therapy
By

By
Pfizer and Akcea Therapeutics, an affiliate of Ionis Pharmaceuticals, specializing in drugs for rare diseases, have entered into an exclusive license agreement for AKCEA-ANGPTL3-LRx, an investigational antisense therapy for patients…

Global Pharma Briefs: News from Europe, Asia and the Middle East
By

By
A roundup of developments and latest news from China (Eisai and Nichi-Iko Pharmaceutical), Israel (Teva) and the UK and Germany (AstraZeneca and Cheplapharm). China Eisai and Nichi-Iko Partner for Generic…